MDxHealth reports Q3 EPS (16c), consensus (12c)

Reports Q3 revenue $27.4M, consensus $24.11M. Michael McGarrity, CEO of mdxhealth (MDXH), commented: “We are pleased to report another strong quarter of growth and operating execution for mdxhealth with 18% revenue growth for the quarter and 20% growth year-to-date, coupled with continued discipline on our operating expenses which were essentially flat on a quarterly and year-to-date basis despite extraordinary ExoDx transaction expenses. Furthermore, total use of cash in Q3 was less than $1M.”